Visceral Fat Gene Expression Linked to Gallstone Risk

A study of women with obesity reveals that changes in specific genes may influence the development of gallstones.

Updated on Oct. 16, 2026 in Weight Loss

Gouache-painted illustration of organic cellular adipose tissue with crystalline structures, representing metabolic health research.
Researchers have identified specific gene expression differences in visceral fat that may contribute to gallstone development in women with obesity. AI Illustration. Upload story photo >

Live Poll

Do you believe recent medical studies are successfully improving treatment options for complex chronic health conditions?

Researchers have identified specific gene expression differences in visceral fat that may contribute to gallstone development in women with obesity. This new study sheds light on the biological factors underlying this increased risk.

Why it matters

Obesity is a known risk factor for gallstones, and understanding these specific metabolic pathways could eventually improve how clinicians approach prevention or risk assessment for patients. These findings help clarify why some individuals are more prone to these painful digestive complications.

This case-control study analyzed a cohort of 108 female patients to compare biological profiles between those with ultrasound-proven gallstones and those without. Researchers observed differences in the expression of 57 genes within visceral adipose tissue, including a decrease in the cholesterol transporter ABCG1.

The players

International Journal of Obesity

A peer-reviewed scientific publication that covers clinical and experimental research regarding obesity and metabolic health.

The details

Researchers utilized fasting plasma metabolomic profiling, fecal shotgun metagenomics, and bulkRNAseq transcriptome analyses of liver and fat biopsies to compare the two groups. They discovered that individuals with gallstones exhibited increased levels of primary and secondary bile acids. Furthermore, the expression of the cholesterol transporter ABCG1 was found to be lower in the visceral adipose tissue of those with the condition, suggesting a specific link between abdominal fat biology and cholesterol metabolism.

Timeline

  1. October 16, 2026: Study results were published in the International Journal of Obesity.

Health Landscape

Medical science has long recognized the strong clinical association between obesity and biliary disease. This study moves beyond that broad correlation to identify potential molecular drivers, marking a shift toward understanding the specific gene expression patterns that may trigger gallstone formation.

If you are managing obesity and have concerns about digestive health, it is worth discussing your individual risk factors for gallstones with your physician. This study underscores why keeping a regular screening schedule is important for those at elevated risk of metabolic conditions.

The takeaway

This research provides a new glimpse into how visceral fat influences the formation of gallstones through gene expression and bile acid metabolism. While this study is preliminary, it highlights the importance of discussing any new abdominal pain or digestive symptoms with your doctor.

Further reading

For more on managing your metabolic health, explore our Weight Loss resources.

More information

View the complete scientific journal research article published in the International Journal of Obesity.

Source note: This article includes information reported by Nature.

Live Poll

Do you believe recent medical studies are successfully improving treatment options for complex chronic health conditions?